Quethera Company

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.
Technology: Gene therapy
Industry: Personalized Medicine
Headquarters: Babraham, Cambridgeshire, United Kingdom
Founded Date: 2013
Employees Number: Undisclosed
Funding Status: M&A

Visit Website
Register and Claim Ownership